
Wednesday, February 07, 2024 3:25:35 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ORIC News
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/03/2025 08:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/24/2025 08:05:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/23/2025 04:15:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 08:05:24 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/11/2025 08:05:51 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/06/2025 08:30:00 PM
- ORIC Pharmaceuticals Shares Rally 20% on Encouraging Cancer Drug Trial and Funding Update • IH Market News • 05/29/2025 02:21:33 PM
- ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing • GlobeNewswire Inc. • 05/28/2025 08:05:00 PM
- ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC • GlobeNewswire Inc. • 05/28/2025 08:05:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/27/2025 08:30:00 PM
- ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC • GlobeNewswire Inc. • 05/27/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2025 08:20:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 08:10:07 PM
- ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates • GlobeNewswire Inc. • 05/05/2025 08:05:00 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/02/2025 08:30:00 PM
- ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/28/2025 08:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2025 08:10:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2025 08:06:42 PM
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/04/2025 08:30:00 PM
- ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/31/2025 08:30:00 PM
- ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 03/25/2025 08:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/20/2025 08:25:15 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM